FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Smart Decision, Inc. Launches CBDSMARTDECISION.COM Web Platform.”
Smart Decision, Inc. (OTC: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce that it has launched their new platform: https://cbdsmartdecision.com, allowing consumers to find the best suited CBD products for their needs.
Smart Decision Inc. has researched and is developing algorithms for the consumer and business LED Lighting and CBD markets. With their patent-pending “Smart Decision” algorithms, the confusion of selecting the right product(s), whether for LED or CBD, will be significantly reduced. Ultimately, Smart Decision Inc. believes that selecting the right product the first time, dramatically cuts down on product returns and creates of positive purchasing experience for the consumer.
Hemp has been used for centuries for its multi-facet applications. Previously, hemp was primarily used for industrial applications such as manufacturing textiles, fabrics, and linen. The industrial segment was the largest driver for the overall hemp market, however, following legislative efforts, the hemp-derived CBD market has emerged as the primary driver. Hemp was also commonly used as a medicinal treatment for convulsions, rheumatism, dysentery, and insomnia. However, health officials around the world had deemed hemp unsafe for consumers because it was derived from the cannabis plant. As a result, the entire cannabis plant was listed as a Schedule 1 substance solely because of its marijuana component. The marijuana plant is packed with tetrahydrocannabinol (THC), while the hemp plant is typically cannabidiol (CBD) dominant. Although the two plants fall under the cannabis family, they are widely different in their genetic makeup and effects. THC is the compound that is commonly known to cause psychoactive effects on the consumer, while CBD is generally known to have relaxing and soothing effects. However, despite the genetic differences, both THC and CBD are known to alleviate certain medical conditions. Researchers have even highlighted that both THC and CBD can effectively treat symptoms associated with cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s. However, because THC causes mind-altering effects, health officials are more inclined to accept CBD as a medicinal treatment than THC. As a result, countries such as Canada, Germany, South Korea, the U.K., and the U.S. have legalized CBD for medical purposes. According to data compiled by Grand View Research, the global cannabidiol market is expected to reach USD 9.69 Billion by 2025 while registering a CAGR of 32.6% during the forecast period.
Predominantly, the overall CBD market is driven by the medical sector. Generally, most consumers intake CBD through forms of capsule or concentrate. And while CBD is typically associated with a medical treatment, in some countries, there are little to no regulations regarding CBD in foods. For instance, in Italy, regulators have allowed CBD oil with 5%, 10%, and 50% to be sold within Italian markets and those categorized under the food aromatic preparations are allowed to be purchased without a prescription. According to the Italian Law 242 of 2016, hemp plants containing less than 0.2% THC is legal and can be used to produce products such as foods and cosmetics, according to Cannabis Radar. Similarly, Canada’s second wave of legalization is underway and is expected to legalize edibles and beverages. On the other hand, in the U.S., it is currently prohibited to add CBD foods and beverages. The U.S. Food and Drug Administration has noted that there is not enough research and data on CBD to approve it as an additive to edibles. Nonetheless, consumers can still easily purchase CBD-based products at their local convenience stores or even on e-commerce platforms. Typically, most consumers tend to purchase CBD capsules or oils, however, products such as topicals, tinctures, edibles, and beverages have become increasingly popular. And while CBD still sits within a gray area of the cannabis market, research and studies are continuing to push CBD into mainstream consumer products. Eventually, industry experts believe that CBD can become more of a supplement like antioxidants and vitamins currently are. “CBD has a number of known properties beneficial to the human condition, and research is just beginning,” Aster Farms President Sam Ludwig told Civilized. “There are two markets for CBD: as a supplement, mild pain reliever and relaxant, and in larger doses, as a truly beneficial remedy for a variety of serious illnesses. There is no doubt it will be dominant supplement for years to come. CBD-heavy flower can be a very effective relaxant for both mind and body. However, people looking for CBD only will find the cleanest and most focused relief in the form of tinctures and capsules. We think the CBD flower market is a trend and will give way to the more concentrated forms. Like an Omega-3 for the body and mind.”
For more information, please visit: Smart Decision, Inc.
For more corporate news on Smart Decision, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.